The Intellectual Property & Science business of Thomson Reuters has announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of Cortellis Informatics Clinical Text Analytics for I2E. The new solution, available through Thomson Reuters Cortellis, a powerful intelligence platform for life science professionals, applies Linguamatics I2E text mining platform to relevant information to assist researchers in finding actionable insights. The content includes clinical trial information, epidemiology data, literature, press releases and conference proceedings.
Cortellis Informatics Clinical Text Analytics for I2E uses the combination of Linguamatics' powerful, market-leading NLP text analytics platform with the largest breadth and depth of integrated clinical content available. Through a single interface, users will be able to glean new insights in support of trials, site selection and competitive intelligence, helping them to design more effective clinical trials and gain a deeper understanding of the implications of their results.
Key features include authoritative, hand-curated content; access to numeric information; data-driven clinical insights; and streamlined search functionality.
